Cernilton

舍尼通

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCernilton
Drug Alias NameCernitin pollen extractCernitinCN-009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPelvic PainProstatitisProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTobishi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity Of Giessen
Active IndicationsProstatic Hyperplasia
Inactive IndicationsPelvic PainProstatitis

Other Information

ATC CodeG04C
Related LinksKEGG